DOI:
10.1055/s-00034914
Osteologie
LinksClose Window
References
Mannstadt M, Clarke BL, Vokes T. et al.
Efficacy and safety of recombinant human parathyroid hormone (1–84) in hypoparathyroidism (REPLACE): A double-blind, placebo-controlled, randomised, phase 3 study.
Lancet Diabetes Endocrinol 2013;
1: 275-283
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.